Yaling H. Liu

215 Heping West Road
Shijiazhuang, 050000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

A phase III clinical trial of PXT3003 in Chinese patients with Charcot-Marie-Tooth disease type 1A.

A phase III clinical trial of PXT3003 in Chinese patients with Charcot-Marie-Tooth disease type 1A.

Journal: iScience

Published: April 15, 2026

Safety and Efficacy of Recombinant Botulinum Toxin Type A (Eveotox®) in Patients with Post-Stroke Upper Limb Spasticity: Results from a Phase Ib/II Clinical Trial.

Safety and Efficacy of Recombinant Botulinum Toxin Type A (Eveotox®) in Patients with Post-Stroke Upper Limb Spasticity: Results from a Phase Ib/II Clinical Trial.

Journal: Toxicon : official journal of the International Society on Toxinology

Published: April 06, 2026

The role of adiponectin and cytokines in Amyotrophic lateral sclerosis: assessment of disease progression and survival status.

The role of adiponectin and cytokines in Amyotrophic lateral sclerosis: assessment of disease progression and survival status.

Journal: Scientific reports

Published: January 27, 2026

Peripheral immune cells and glycation indices as potential diagnostic biomarkers in amyotrophic lateral sclerosis.

Peripheral immune cells and glycation indices as potential diagnostic biomarkers in amyotrophic lateral sclerosis.

Journal: Experimental biology and medicine (Maywood, N.J.)

Published: January 15, 2026

Administration practice and adherence of nusinersen in adults with 5q-spinal muscular atrophy in China: an ambispective multicenter study.

Administration practice and adherence of nusinersen in adults with 5q-spinal muscular atrophy in China: an ambispective multicenter study.

Journal: BMC neurology

Published: November 11, 2025

Effectiveness and Safety of Nusinersen Among Adults with 5q-Spinal Muscular Atrophy: A Multicenter Disease Registry in China.

Effectiveness and Safety of Nusinersen Among Adults with 5q-Spinal Muscular Atrophy: A Multicenter Disease Registry in China.

Journal: Advances in therapy

Published: September 15, 2025

Glymphatic dysfunction in amyotrophic lateral sclerosis: a multimodal MRI investigation of brain-CSF functional and structural dynamics.

Glymphatic dysfunction in amyotrophic lateral sclerosis: a multimodal MRI investigation of brain-CSF functional and structural dynamics.

Journal: Frontiers in neuroscience

Published: July 15, 2025

Development and validation of a predictive model for depression risk in patients with amyotrophic lateral sclerosis.

Development and validation of a predictive model for depression risk in patients with amyotrophic lateral sclerosis.

Journal: Frontiers in neurology

Published: June 02, 2025

Comparative efficacy of fractional CO₂ laser combined with concentrated growth factor (CGF) for treating hypertrophic scars in rabbit ears.

Comparative efficacy of fractional CO₂ laser combined with concentrated growth factor (CGF) for treating hypertrophic scars in rabbit ears.

Journal: Lasers in medical science

Published: May 08, 2025

Unlocking amyotrophic lateral sclerosis: the role of adiponectin in inflammation and disease progression.

Unlocking amyotrophic lateral sclerosis: the role of adiponectin in inflammation and disease progression.

Journal: Frontiers in neurology

Published: April 04, 2025

Correction: Simvastatin accelerated motoneurons death in SOD1G93A mice through inhibiting Rab7-mediated maturation of late autophagic vacuoles.

Correction: Simvastatin accelerated motoneurons death in SOD1G93A mice through inhibiting Rab7-mediated maturation of late autophagic vacuoles.

Journal: Cell death & disease

Published: February 27, 2025

Tetramethylpyrazine Nitrone in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.

Tetramethylpyrazine Nitrone in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.

Journal: JAMA network open

Published: February 24, 2025

Showing 1-12 of 51

Last Updated: 09/26/2026